# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 05-14-2024 | 03-31-2024 | 10-Q | |
2 | 03-29-2024 | 12-31-2023 | 10-K | |
3 | 11-14-2023 | 09-30-2023 | 10-Q | |
4 | 10-18-2023 | 06-30-2023 | 10-Q |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Needham analyst Chris Pierce reiterates Urgently (NASDAQ:ULY) with a Buy and maintains $5 price target.
Needham analyst Chris Pierce reiterates Urgently (NASDAQ:ULY) with a Buy and maintains $5 price target.
Urgently (NASDAQ:ULY) reported quarterly losses of $(0.97) per share which missed the analyst consensus estimate of $(0.92) by ...
Needham analyst Chris Pierce maintains Urgently (NASDAQ:ULY) with a Buy and lowers the price target from $7 to $5.
Urgently (NASDAQ:ULY) reported quarterly earnings of $11.95 per share. The company reported $45.05 million in sales this quart...
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
Urgent.ly, Inc. (NASDAQ:ULY) ("Urgently"), a U.S.-based leading provider of digital roadside and mobility assistance te...
Needham analyst Chris Pierce reiterates Urgently (NASDAQ:ULY) with a Buy and maintains $7 price target.
Needham analyst Chris Pierce initiates coverage on Urgently (NASDAQ:ULY) with a Buy rating and announces Price Target of $7.